Home > Drug Search >
  • company_query: Australian National University
  •   > 
Drug Filter
Category:
chemistry (8) biology (20)
Status:
Approved (4) Withdrawn (1) Phase Ⅲ (4) Phase Ⅱ (14) Phase Ⅰ (4)
Clinical Stage:
Pending (3) Active (18) Discontinued (2)
Bio-Type:
Gene therapy (2) Cell therapy (1) CAR T cell therapy (4) Vaccine (3) Recombinant cytokines (2) Recombinant hormone (1) Bispecific antibody (1) Whole antibody (2) ADC (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (2) Acute myeloid Leukemia (AML) (1) Anemia (1) Anxiety (1) Asthma (2) Breast cancer (4) Chronic lymphocytic leukemia (CLL) (1) Chronic obstructive pulmonary disease (COPD) (1) Cutaneous T cell lymphoma (CTCL) (1) Cystic fibrosis (CF) (1) Gastric cancer (1) Cytomegalovirus infections (1) Heart failure (1) HIV infection (2) Leukemia (1) Melanoma (3) Multiple myeloma (MM) (2) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin B-cell lymphomas (2) Non-Hodgkin’s lymphoma (NHL) (1) Lung disorders (1) Ovarian cancer (3) Pancreatic cancer (1) Haemophilus infection (1) Solid tumours (4) Head and neck cancer (1) Colorectal cancer (1) Cirrhosis (1) Chronic heart failure (1) Sarcoma (1) Neutropenia (1) Hematological cancer (1) Portal hypertension (1) Acute heart failure (1) Esophageal adenocarcinoma (1) Merkel cell carcinoma (1) Plaque psoriasis (1) Panic disorder (1) Coronary heart disease (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top